GlaxoSmithKline Czech Republic made a net profit of CZK 65.4 mil with revenues of CZK 2,897 mil in 2017, up by 72% and down by 14.6%, respectively, compared to the previous year.
This translates into a net margin of 2.26%. Historically, between 2003 and 2017, the firm’s net margin reached a high of 4.12% in 2011 and a low of -0.197% in 2006. The average net margin in the last five years amounted to 2.06%.
On the operating level, the EBITDA margin reached 3.36% and EBIT amounted to 3.10% of sales in 2017.
You can see all the company’s data at GlaxoSmithKline Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
